IDH1 R132H
|
Anaplastic Astrocytoma
|
IDH1 R132H
|
Anaplastic Astrocytoma
|
temozolomide Sensitive: B - Late Trials
|
temozolomide Sensitive: B - Late Trials
|
IDH1 R132H
|
AML
|
IDH1 R132H
|
AML
|
dasatinib Sensitive: C3 – Early Trials
|
dasatinib Sensitive: C3 – Early Trials
|
IDH1 R132H
|
AML
|
IDH1 R132H
|
AML
|
midostaurin Sensitive: C4 – Case Studies
|
midostaurin Sensitive: C4 – Case Studies
|
IDH1 R132H
|
Glioma
|
IDH1 R132H
|
Glioma
|
PD-L1 inhibitor + IDH1 inhibitor Sensitive: D – Preclinical
|
PD-L1 inhibitor + IDH1 inhibitor Sensitive: D – Preclinical
|
IDH1 R132H
|
Glioma
|
IDH1 R132H
|
Glioma
|
olaparib + AZD6738 Sensitive: D – Preclinical
|
olaparib + AZD6738 Sensitive: D – Preclinical
|
IDH1 R132H
|
AML
|
IDH1 R132H
|
AML
|
venetoclax + midostaurin + LY3410738 Sensitive: D – Preclinical
|
venetoclax + midostaurin + LY3410738 Sensitive: D – Preclinical
|
IDH1 R132H
|
Glioma
|
IDH1 R132H
|
Glioma
|
AGI-5198 Sensitive: D – Preclinical
|
AGI-5198 Sensitive: D – Preclinical
|
IDH1 R132H
|
AML
|
IDH1 R132H
|
AML
|
GSK321 Sensitive: D – Preclinical
|
GSK321 Sensitive: D – Preclinical
|